Mabgenex
(MABGENEX PRIVATE LIMITED)
Founded in 2018
About Mabgenex
Mabgenex is a startup that specializes in AI-driven biologics. They offer innovative solutions in therapeutics and diagnostics by replicating the complex process of selecting antigen-specific antibodies. By combining biology with machine learning, it generates highly specific and sensitive antibodies to address unmet needs in the field.
Incubators & Accelerators of Mabgenex
+1 more incubator
Public Links of Mabgenex
Frequently Asked Questions (FAQ)
When was Mabgenex founded?
Mabgenex was founded in the year 2018.
What is the legal name of Mabgenex?
The legal name of Mabgenex is Mabgenex Private Limited.
Who are the founders of Mabgenex?
Mabgenex is founded by Jaya Laxmi Chintalapati and Suresh Kumar Chintalapati.
Which Incubators & Accelerators supported Mabgenex?
What are the focus areas of Mabgenex?
Who are Mabgenex's competitors?
Possible competitors of Mabgenex may include 2mbigway.com, Arficus, Dasa Labs Private Limited and 7 others.
Get Access to Complete Information
Signup NowYNOS is not associated with any of the entities (organisations / people) mentioned in this page. Information provided here has been curated from multiple public as well as proprietary sources. All efforts have been taken to make it accurate and complete. If details are insufficient or not accurate, kindly suggest edits
Get more information with Govt. Funding
Discover & analyse the best government funding avenues for your startup in India.
Get more information with Debt Funding
Discover Top Loan & Debt Funding Schemes for Startups in India.
Get more information with Incubators
The Ultimate Platform for Finding the Right Incubator and Accelerator.
Get more information with Insight
The most powerful dashboard solution on Indian Startups & Investors.
Try StartupGPT, an AI-Assistant for Founders & Investors
Your conversational companion for Indian Startups, Funding, and much more.
- slide 1 of 8, currently active
- slide 2 of 8
- slide 3 of 8
- slide 4 of 8
- slide 5 of 8
- slide 6 of 8
- slide 7 of 8
- slide 8 of 8
